Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Ned Tijdschr Geneeskd ; 1642020 11 19.
Artigo em Holandês | MEDLINE | ID: mdl-33332024

RESUMO

Fluoroquinolones are frequently prescribed antibiotics. Recently, the Dutch medicines evaluation board CBG warned about the risk of aortic aneurysms and dissections with the use of fluoroquinolones. We reviewed the three articles used in this warning. We consider that the evidence for a causal relationship is limited. The hazard ratio for the association with fluoroquinolones and aortic aneurysms was around 2. The absolute risk is low given the low prevalence in the general population. However, aortic aneurysms and dissections are life-threatening conditions and must be taken serious. We advise what to do in case of known aortic aneurysms or the presence of multiple risk factors.


Assuntos
Antibacterianos/efeitos adversos , Aneurisma Aórtico/induzido quimicamente , Dissecção Aórtica/induzido quimicamente , Fluoroquinolonas/efeitos adversos , Idoso , Humanos , Masculino , Fatores de Risco
3.
Br J Pharmacol ; 157(6): 931-4, 2009 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-19466986

RESUMO

BACKGROUND AND PURPOSE: Aspirin reduces the risk of myocardial infarction and stroke by inhibiting thromboxane production in platelets. This inhibition can be competitively antagonized by some non-steroidal anti-inflammatory drugs (NSAIDs). EXPERIMENTAL APPROACH: By measuring thromboxane B(2) production in healthy volunteers, we investigated whether ibuprofen (800 mg three times daily for 7 days) or diclofenac (50 mg three times daily for 7 days) taken concurrently with aspirin 80 mg (once daily for 7 days) influenced the inhibitory effect of aspirin. The effects were compared with aspirin 30 mg (once daily for 7 days), which is the lowest dose of aspirin with a proven thromboprophylactic effect. KEY RESULTS: The median percentage inhibition of thromboxane B(2) levels by 30 mg or 80 mg aspirin was 90.3% (range 83.1-96.0%) and 98.0% (range 96.8-99.2%) respectively. The inhibition by concurrent administration of slow release diclofenac and 80 mg aspirin was 98.1% (range 97.2-98.9%), indicating no interference between aspirin and diclofenac. The inhibition decreased significantly by concurrent administration of immediate release ibuprofen and 80 mg aspirin (86.6%; range 77.6-95.1%) to a level less than 30 mg aspirin. CONCLUSIONS AND IMPLICATIONS: As alternatives are easily available, NSAIDs such as diclofenac should be preferred to ibuprofen for combined use with aspirin.


Assuntos
Anti-Inflamatórios não Esteroides/sangue , Aspirina/sangue , Ibuprofeno/sangue , Adulto , Anti-Inflamatórios não Esteroides/farmacocinética , Aspirina/antagonistas & inibidores , Aspirina/farmacocinética , Estudos Cross-Over , Preparações de Ação Retardada , Diclofenaco/sangue , Diclofenaco/farmacocinética , Interações Medicamentosas/fisiologia , Feminino , Humanos , Ibuprofeno/farmacocinética , Masculino , Pessoa de Meia-Idade , Agregação Plaquetária/efeitos dos fármacos , Agregação Plaquetária/fisiologia , Fatores de Risco , Tromboxano B2/antagonistas & inibidores , Tromboxano B2/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA